What's new

Human medicines European public assessment report (EPAR): Sondelbay, teriparatide, Date of authorisation: 24/03/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Sondelbay, teriparatide, Date of authorisation: 24/03/2022, Revision: 2, Status: Authorised

May 15, 2025 - 11:38
 0
Human medicines European public assessment report (EPAR): Sondelbay, teriparatide, Date of authorisation: 24/03/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Sondelbay, teriparatide, Date of authorisation: 24/03/2022, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Next Article

Bi-annual Familiarization Programme demonstrates NATO’s strong commitment and de...

Related Posts

Human medicines European public assessment report (EPAR): Sunitinib Accord, sunitinib, Date of authorisation: 11/02/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

Referral: Ixchiq, Chikungunya vaccine (live) Article 20 procedures Procedure started, 08/05/2025

Referral: Ixchiq, Chikungunya vaccine (live) Article 20...

May 8, 2025  0

Workshop on the use of Bayesian statistics in clinical development, Online, European Medicines Agency, Amsterdam, the Netherlands, 17 June 2025

Workshop on the use of Bayesian statistics in clinical ...

May 7, 2025  0